Transformational mega-deals reshape industry landscape as transaction volume increases 5% over previous year, MarshBerry reports.

Transactional risk insurance market hits record highs as M&A activity rebounds across North America, Marsh reports.

Insurance M&A activity expected to rise in 2025 despite fewer deals and extended completion timelines in 2024, Deloitte reports.

Charlie Tice is the Private Equity National Practice Lead for Travelers. Risk & Insurance recently spoke to him as part of our expanded coverage of our 2025 M&A Power Broker® winners and finalists.

This year seven brokers were selected as M&A Power Brokers.

Spotlighting the next generation of insurance talent, Risk & Insurance spoke with Marsh’s Kurt Spielmann.

Insureds may feel uncertainty when their carrier announces an M&A. Stability and transparent communication can help.

M&A activity in the insurance industry stabilizes as a steady supply of sellers meets a diverse buyer landscape, according to to the latest Q3 2024 update from Optis Partners .

Insurance M&A activity declines to 16-quarter low, but is higher than a decade ago and private equity interest remains strong, according to OPTIS Partners analysis.

R&W insurance uptake is increasing — here’s why.

Amid rising interest rates and elevated valuations, Q1 sees a slowdown in M&A activity in the insurance distribution sector, OPTIS Partners reports

The Hartford joins a growing-list of insurers that have withdrawn from California’s homeowners insurance market.

Despite a dip in M&A activity in 2023, transactional risk insurance thrived, with tech leading the pack in deal value, reveals a Marsh report.

After a lull in 2023, Deloitte predicts a resurgence in insurance M&A activity in 2024, driven by private equity and external investments.

Six brokers were selected as M&A Power Brokers, with two finalists.

CAC Specialty’s Vara Pikor Cybart discusses the changes she’s seeing in the M&A space and how she adapts in real time.

This year, 6 brokers from across the brokerage field were named as the 2023 M&A Power Broker winners. An additional five brokers were named as finalists.

Digital transformation, clinical trials, climate change and product recalls are among the top risks and opportunities facing the life sciences sector over the next several years.

M&A is surging in health care. Hospitals and other facilities must review their internal controls before enacting on a deal.

The rush to create tech companies to meet a growing digital need has opened the door to more M&A activity. But with tech, cyber risk abounds.